4D Molecular Therapeutics, Inc. 8-K

Accession 0001193125-23-282259

Filing information

CIK: 0001650648
Report date: 2023-11-16
Filing date: 2023-11-22
Form: 8-K
Primary document: d797882d8k.htm

Open primary document

View the filing document on sec.gov.

Open EDGAR directory

Inspect all files for this filing.

Complete submission file

Open the raw SEC submission text.